MNL-00008 [5]
Proprietary and Confidential Page
47
of
55
Maximum Number of Treatments = 29
SKIN TYPES I & II, ALL SCHEDULES
% of
MED
% INCREASE OVER PREVIOUS DOSE
TREATMENT #
1
2
3
4
5
6
7
8
9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28
29
PRIMARY DOSE (MILLIJOULES)
70
10 10 10 10 10 10 10 10 10 10 10 10 10 9
8
7
6
5
4
3
2
1
0
0
0
0
0
0
% OF PRIMARY DOSE
SECONDARY DOSE (MILLIJOULES)
50
50 50 50 50 50 50 50 50 50 50 50 50 50 50 50 50 50 50 50 50 50 50 50 50 50 50 50
50
SKIN TYPES III & IV, ALL SCHEDULES
% of
MED
% INCREASE OVER PREVIOUS DOSE
TREATMENT #
1
2
3
4
5
6
7
8
9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28
29
PRIMARY DOSE (MILLIJOULES)
70
15 15 15 15 15 15 15 15 15 15 15 14 13 12 11 10 9
8
7
6
5
4
3
2
1
0
0
0
% OF PRIMARY DOSE
SECONDARY DOSE (MILLIJOULES)
50
50 50 50 50 50 50 50 50 50 50 50 50 50 50 50 50 50 50 50 50 50 50 50 50 50 50 50
50
SKIN TYPES V & VI, ALL SCHEDULES
% of
MED
% INCREASE OVER PREVIOUS DOSE
TREATMENT #
1
2
3
4
5
6
7
8
9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28
29
PRIMARY DOSE (MILLIJOULES)
70
15 15 15 15 15 15 15 15 15 15 15 15 15 14 13 12 11 10 9
8
7
6
5
4
3
2
1
0
% OF PRIMARY DOSE
SECONDARY DOSE (MILLIJOULES)
50
50 50 50 50 50 50 50 50 50 50 50 50 50 50 50 50 50 50 50 50 50 50 50 50 50 50 50
50
23.14
HI Dose Narrow Band UVB Maintenance Phase Protocols:
1/WEEK
Maximum Number of Treatments = 4
ALL SKIN TYPES:
Dose should be held steady at last clearance phase dose.
